Somatostatin receptors as a new active targeting sites for nanoparticles

被引:20
作者
Abdellatif, Ahmed A. H. [1 ,2 ]
Aldalaen, Sa'ed M. [3 ]
Faisal, Waleed [5 ,6 ]
Tawfeek, Hesham M. [3 ,4 ]
机构
[1] Al Azhar Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, Assiut 71524, Egypt
[2] Qassim Univ, Fac Pharm, Dept Pharmaceut, Buraydah 51452, Al Qassim, Saudi Arabia
[3] Mutah Univ, Dept Pharmaceut & Pharmaceut Technol, Fac Pharm, Mutah 61710, Al Karak, Jordan
[4] Assiut Univ, Dept Ind Pharm, Fac Pharm, Assiut 71526, Egypt
[5] Menia Univ, Dept Pharmaceut, Fac Pharm, Al Minya, Egypt
[6] Univ Coll Cork, Sch Pharm, Cork, Ireland
基金
欧盟地平线“2020”;
关键词
Active targeting; Somatostatin analogues; Somatostatin receptors; Nanoparticles; Cellular uptake; HUMAN ENDOCRINE TUMORS; QUANTUM DOTS; GOLD NANOPARTICLES; IN-VIVO; THYROID-CANCER; BREAST-CANCER; NEUROENDOCRINE TUMORS; MOLECULAR TARGETS; COLORECTAL-CANCER; INSULINOMA CELLS;
D O I
10.1016/j.jsps.2018.05.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The delivery of nanoparticles through receptor-mediated cell interactions has nowadays a major attention in the area of drug targeting applications. This specific kind of targeting is mediated by localized receptors impeded into the target site with subsequent drugs internalization. Hence, this type of interaction would diminish side effects and enhance drug delivery efficacy to the target site. Somatostatin receptors (SSTRs) are one type of G protein-coupled receptors, which could be active targeted for various purposes. There are five SSTRs types (SSTR1-5) which are localized at various organs in the body and spread into different tissues. SSTRs could be considered as a promising target to various nanoparticles which is facilitated when nanoparticles are modified through specific ligand or coating to allow better binding. This review discusses the exploration of SSTRs for active targeting of nanoparticles with certain emphasize on their interaction at the cellular level. (C) 2018 The Authors. Production and hosting by Elsevier B.V.
引用
收藏
页码:1051 / 1059
页数:9
相关论文
共 125 条
  • [1] ABDELLATIF AA, 2015, J NANOMED NANOTECH S, V6, P1
  • [2] ABDELLATIF AA, 2016, DRUG DEV IND PHARM, P1
  • [3] Abdellatif AAH, 2015, INT J PHARM SCI RES, V7, P14
  • [4] Novel gold nanoparticles coated with somatostatin as a potential delivery system for targeting somatostatin receptors
    Abdellatif, Ahmed A. H.
    Zayed, Gamal
    El-Bakry, Asmaa
    Zaky, Alaa
    Saleem, Imran Y.
    Tawfeek, Hesham M.
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (11) : 1782 - 1791
  • [5] Colorectal cancer targeted Irinotecan-Assam Bora rice starch based microspheres: a mechanistic, pharmacokinetic and biochemical investigation
    Ahmad, Mohammad Zaki
    Akhter, Sohail
    Anwar, Mohammed
    Kumar, Atul
    Rahman, Mahfoozur
    Talasaz, Azita Hajhossein
    Ahmad, Farhan Jalees
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2013, 39 (12) : 1936 - 1943
  • [6] Metallic nanoparticles: technology overview & drug delivery applications in oncology
    Ahmad, Mohammad Zaki
    Akhter, Sohail
    Jain, Gaurav Kumar
    Rahman, Mahfoozur
    Pathan, Shadab Ahmad
    Ahmad, Farhan Jalees
    Khar, Roop Krishen
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (08) : 927 - 942
  • [7] Cancer Targeted Metallic Nanoparticle: Targeting Overview, Recent Advancement and Toxicity Concern
    Akhter, Sohail
    Ahmad, Mohammad Zaki
    Singh, Anjali
    Ahmad, Iqbal
    Rahman, Mahfoozur
    Anwar, Mohammad
    Jain, Gaurav Kumar
    Ahmad, Farhan Jalees
    Khar, Roop Krishen
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (18) : 1834 - 1850
  • [8] Targeted cancer therapy through antibody fragments-decorated nanomedicines
    Alibakhshi, Abbas
    Kahaki, Fatemeh Abarghooi
    Ahangarzadeh, Shahrzad
    Yaghoobi, Hajar
    Yarian, Fatemeh
    Arezumand, Roghaye
    Ranjbari, Javad
    Mokhtarzadeh, Ahad
    de la Guardia, Miguel
    [J]. JOURNAL OF CONTROLLED RELEASE, 2017, 268 : 323 - 334
  • [9] Aneja Preeti, 2014, Recent Pat Antiinfect Drug Discov, V9, P121
  • [10] Thyroid-Associated Ophthalmopathy and TSH Receptor Autoantibodies in Nonmetastatic Thyroid Cancer After Total Thyroidectomy
    Antonelli, Alessandro
    Fallahi, Poupak
    Tolari, Simone
    Ferrari, Silvia Martina
    Ferrannini, Ele
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2008, 336 (03) : 288 - 290